Benefits of probiotics in the treatment of abdominal and pelvic cancers
I have just read the excellent article by Prof. Paul Enck, a microbiota specialist in Germany, on the conclusions of a recent study on the association of probiotics with certain anti-cancer treatments. The use of probiotics by patients with abdominal and pelvic cancers undergoing radiotherapy or chemotherapy, would have a beneficial effect on the incidence of grade ≥2 diarrhea associated with these treatments, without significant adverse effects.
This is the conclusion highlighted in a systematic review and meta-analysis of 9 studies involving 1,265 participants conducted by Dr. C-W Pei at the end of 2016 at the Clinical Medical College and Evidence Based Medical Center in Lanzhou, China. 1